Fingerprint
Dive into the research topics of 'Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically